Every day, Cranberry resident Margarita Hornung realizes how lucky she is to be alive to be with her husband, Mike, and her two children, 15-year-old Noah and 9-year-old Paulina.
Just five years ago, .
Discussion centered around data from the PAOLA-1 trial, highlighting the prevalence of BRCA1/2 mutations and HRD status in ovarian cancer, and how patients with these alterations may benefit from PARP inhibitor treatment.